Dramatic Clinical Response of Relapsed Metastatic Extramammary Paget's Disease to Trastuzumab Monotherapy

We report the first case of 68-year-old Japanese woman with metastatic HER2-positive extramammary Paget's disease that showed the validity of trastuzumab monotherapy. We administered trastuzumab at a loading dose of 8 mg/kg i.v., followed by a 6 mg/kg maintenance dose every three weeks accordin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakabayashi, S., Togawa, Y., Yoneyama, K., Suehiro, K., Kambe, N., Matsue, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505941/
https://www.ncbi.nlm.nih.gov/pubmed/23259081
http://dx.doi.org/10.1155/2012/401362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505941/
https://www.ncbi.nlm.nih.gov/pubmed/23259081
http://dx.doi.org/10.1155/2012/401362

Ejemplares similares